City National Bank of Florida’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$985K Buy
3,915
+961
+33% +$207K 0.41% 46
2026
Q1
$642K Buy
2,954
+219
+8% +$48.6K 0.38% 56
2025
Q4
$625K Buy
2,735
+277
+11% +$63.1K 0.41% 44
2025
Q3
$569K Buy
2,458
+125
+5% +$25.5K 0.38% 48
2025
Q2
$433K Buy
2,333
+567
+32% +$105K 0.32% 62
2025
Q1
$370K Buy
1,766
+103
+6% +$20K 0.33% 65
2024
Q4
$296K Buy
+1,663
New +$306K 0.27% 79

Other funds holding ABBV

City National Bank of Florida's ABBV Position: Q2 2026 in Review

City National Bank of Florida increased its AbbVie (ABBV) stake by 33% in Q2 2026, buying an estimated $207K and bringing the position to 3,915 shares worth $985K. The position accounts for 0.41% of the portfolio, ranked #46.

City National Bank of Florida first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 3,435 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • City National Bank of Florida held 3,915 shares of AbbVie worth $985K as of Q2 2026.
  • City National Bank of Florida bought 961 AbbVie shares in Q2 2026, an estimated $207K.
  • AbbVie made up 0.41% of City National Bank of Florida's portfolio in Q2 2026, its #46 holding.
  • City National Bank of Florida first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 3,435 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on City National Bank of Florida's 13F filing for Q2 2026, filed 15 Jul 2026.